《港股》恆指半日跌254點 百度、蔚來及藥股下滑
港股早市先升後跌,恆指高開91點,初段升109點見26,454點後向下,曾跌283點見26,060點,半日跌254點或1%,報26,090點;國指跌109點或1.2%,報9,261點;恆生科技指數跌137點或2.2%,報6,120點。大市半日成交總額1,652.3億元。
百度(09888.HK)股價回吐7.6%,野村指8月份總使用時長(MTS)按年下滑6%,主要受到每日活躍用戶(DAU)按年下降10%的拖累,即使人均日使用時長(DTSD)錄得5%的增長,亦不足以抵消影響。京東工業擬赴港上市獲中證監備案,京東(09618.HK)回吐4.8%。雲智匯科技(01037.HK)與優必選(09880.HK)簽訂潛在戰略合作諒解備忘,雲智匯科技升79%,優必選跌3.2%。
蘋果概念股藍思科技(06613.HK)跌7.1%,比亞迪電子(00285.HK)、舜宇(02382.HK)及丘鈦(01478.HK)跌3%至3.6%。晶片股中芯(00981.HK)及華虹(01347.HK)回吐2.6%及4.1%。其他科技股方面,阿里(09988.HK)、騰訊(00700.HK)、小米(01810.HK)及快手(01024.HK)跌0.7%至1.6%,美團(03690.HK)及嗶哩嗶哩(09626.HK)跌2.5%及4.4%。此外,東方甄選(01797.HK)及微盟(02013.HK)跌4.9%及5.1%。
車股理想(02015.HK)及比亞迪(01211.HK)跌2.8%及3.6%,蔚來(09866.HK)跌7.4%,電池股寧德時代(03750.HK)跌2.6%,汽車代理中升(00881.HK)跌2.9%。消費股普遍下跌,泡泡瑪特(09992.HK)、李寧(02331.HK)及九毛九(09922.HK)跌2.8%至3.3%,名創優品(09896.HK)跌4.4%。旅遊相關股方面,國航(00753.HK)及中免(01880.HK)跌3.6%及3.7%,南航(01055.HK)跌5.2%。
醫藥股回吐,藥明康德(02359.HK)、恆瑞(01276.HK)、百濟神州(06160.HK)、康希諾(06185.HK)及中生製藥(01177.HK)跌4%至4.9%,康龍化成(03759.HK)及石藥(01093.HK)跌逾5%。
金融股匯控(00005.HK)升0.7%報108元、港交所(00388.HK)及友邦(01299.HK)跌1.5%及0.7%。內險股眾安在線(06060.HK)跌3.3%。
其他股份方面,中國罕王(03788.HK)折讓14.7%向紫金(02899.HK)發新股,籌逾2.3億元,中國罕王升16.6%,紫金跌0.7%。阜博(03738.HK)擬溢價15.1%發行16億元零息可換股債,股價升3.9%。地產股新世界(00017.HK)跌4.7%。山高控股(00412.HK)半日升14.5%報4.99元,成交25.85億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.